1. Home
  2. PRPH vs RMCO Comparison

PRPH vs RMCO Comparison

Compare PRPH & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPH
  • RMCO
  • Stock Information
  • Founded
  • PRPH 1989
  • RMCO 2021
  • Country
  • PRPH United States
  • RMCO United States
  • Employees
  • PRPH N/A
  • RMCO N/A
  • Industry
  • PRPH Biotechnology: Pharmaceutical Preparations
  • RMCO Multi-Sector Companies
  • Sector
  • PRPH Health Care
  • RMCO Miscellaneous
  • Exchange
  • PRPH Nasdaq
  • RMCO Nasdaq
  • Market Cap
  • PRPH 15.2M
  • RMCO 14.9M
  • IPO Year
  • PRPH 1997
  • RMCO N/A
  • Fundamental
  • Price
  • PRPH $0.36
  • RMCO $1.31
  • Analyst Decision
  • PRPH
  • RMCO
  • Analyst Count
  • PRPH 0
  • RMCO 0
  • Target Price
  • PRPH N/A
  • RMCO N/A
  • AVG Volume (30 Days)
  • PRPH 813.9K
  • RMCO 127.4K
  • Earning Date
  • PRPH 08-13-2025
  • RMCO 08-14-2025
  • Dividend Yield
  • PRPH N/A
  • RMCO 0.40%
  • EPS Growth
  • PRPH N/A
  • RMCO N/A
  • EPS
  • PRPH N/A
  • RMCO N/A
  • Revenue
  • PRPH $5,845,000.00
  • RMCO $1,568,212.00
  • Revenue This Year
  • PRPH $221.82
  • RMCO N/A
  • Revenue Next Year
  • PRPH N/A
  • RMCO N/A
  • P/E Ratio
  • PRPH N/A
  • RMCO N/A
  • Revenue Growth
  • PRPH N/A
  • RMCO 204.08
  • 52 Week Low
  • PRPH $0.22
  • RMCO $0.76
  • 52 Week High
  • PRPH $3.37
  • RMCO $1.88
  • Technical
  • Relative Strength Index (RSI)
  • PRPH 46.36
  • RMCO 50.40
  • Support Level
  • PRPH $0.35
  • RMCO $1.18
  • Resistance Level
  • PRPH $0.46
  • RMCO $1.35
  • Average True Range (ATR)
  • PRPH 0.03
  • RMCO 0.17
  • MACD
  • PRPH -0.01
  • RMCO -0.02
  • Stochastic Oscillator
  • PRPH 19.36
  • RMCO 15.00

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

About RMCO Royalty Management Holding Corporation

Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.

Share on Social Networks: